Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline SOJF Q1 2026 Earnings EPS Beats Estimates Driven by Strong Utility Operations MDCX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Posts WiderthanExpected Loss PWP Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Weakness ADXN Q1 2024 Earnings EPS Reported at 1227 No Revenue as DevelopmentStage Biotech Continues Crexendo CXDO Q1 2026 Earnings EPS Surges Past Estimates by 256 Amid Sparse Revenue Disclosure